´â·Ç¼¨ÈÄTOP ·Ç¼¨ÈÄ ¥Á¥ã¥Ã¥È ¾ðÊ󸡺÷ Wiki ¼­Åµ ÏÀʸ ¥ê¥ó¥¯½¸ ¥¢¥ó¥±¡¼¥È Êݸ± ½ñÀÒ ÍÑÉÊ
£Í£ù¥í¥°¥¤¥ó

ÏÀʸʣ¼Ì

  Á´Ê¸¸¡º÷
¾ÜºÙ¸¡º÷  
  ÏÀʸʣ¼Ì » À©´âºÞÅù_ά¹æ » CPT-11 ¥¢¥«¥¦¥ó¥È¾ðÊó  |  ¥«¡¼¥È¤ò¸«¤ë  |  ¥ì¥¸¤Ë¿Ê¤à   
´Êñ¸¡º÷
« À©´âºÞÅù_ά¹æ»
  254-S
  5-FU
  ADM
  ANA
  Ara-c
  ATRA
  CDGP
  CPA
  CPM
CPT-11
  DTIC
  DXR
  EPI
  G-CSF
  GEM
  IFM
  IFX
  L-OHP
  L-PAM
  NDP
  OK-432
  PEP
  SPAC
  STI571
  TAM
  TS-1 + ž°Ü
  TS-1¡Ü°ß´â
  TXL
  TXT
  UFT
  VCR
  VNR
  ZD1839
  ZOL
¥«¥Æ¥´¥ê¡¼¤Çõ¤¹ ÅÐÏ¿¹àÌܤÇõ¤¹
½ÐÈÇÃÄÂÎÊ̤Çõ¤¹½ÐÈÇÊ̤Çõ¤¹
°ìÍ÷¤Çõ¤¹ °ìÍ÷ɽ¼¨¤Çõ¤¹
¶È̳¡¦ÄêµÙ
ÀÖ¤ÎÆü¤ÏȯÁ÷¤ò¤ªµÙ¤ß¤µ¤»¤Æ¤¤¤¿¤À¤­¤Þ¤¹¡£
2008ǯ10·î
Æü ·î ²Ð ¿å ÌÚ ¶â ÅÚ
¡¡ ¡¡ ¡¡ 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 ¡¡
¡¡
¥¤¥ó¥Õ¥©¥á¡¼¥·¥ç¥ó
¥Ë¥å¡¼¥¹
¤´ÍøÍÑÊýË¡
¸Ä¿Í¾ðÊóÊݸîÊý¿Ë
Áí³Ûɽ¼¨¤Ë¤Ä¤¤¤Æ
ÆÃÄ꾦¼è°úË¡¤Îɽ¼¨
¤è¤¯¤¢¤ë¼ÁÌä
¡¡¡¡¡ú²Á³Ê¤Ï¡©
¡¡¡¡¡ú»Ùʧ¤¤¤Ï¡©
¡¡¡¡¡úǼ´ü¤Ï¡©
¤ªÌ䤤¹ç¤ï¤»
¥µ¥Ý¡¼¥È·Ç¼¨ÈÄ

´Êñ¸¡º÷ Topotecin or ¥¤¥ê¥Î¥Æ¥«¥ó or CPT-11 or Irinotecan or campto

¤³¤Î¥­¡¼¥ï¡¼¥É¤ÎRSS2.0
¡¡¹¹¤Ë¹Ê¹þ¤à: ¡¡
21-Supplement ­µ 21-Supplement ­µ

 ¿·Ãå½ç+   Ž×ŽÝŽ·ŽÝޏŽÞ 
 
¡ùÀÚ½üÉÔǽ¿Ê¹Ô°ß´â¤ËÂФ¹¤ëFifth-Line²½³ØÎÅË¡¤È¤·¤ÆmFOLFOX6ÎÅË¡¤¬ÁÕ¸ú¤·¤¿1Îã

  ¢£Á°¼£ÎÅ...taxane,CDDP,CPT-11.ÅêÍ¿¡¡oxaliplatin-based²½³ØÎÅË¡...mFOLFOX 6ÎÅË¡.»Ü¹Ô¡¡ÁÕ¸ú..ÀÚ½üÉÔǽ¿Ê¹Ô°ß´â¾ÉÎã¡¡73ºÐ,ÃËÀ­¡¡¸ú...

  ¢£*1»¥ËÚ°å²ÊÂç³Ø°å³ØÉô¡¦Âè»ÍÆâ²Ê, *2Å컥ËÚɱ¡¡¦Æâ²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ù

º£¤¹¤° ÀÚ½üÉÔǽ¿Ê¹Ô°ß´â¤ËÂФ¹¤ëFifth-Line²½³ØÎÅË¡¤È¤·¤ÆmFOLFOX6ÎÅË¡¤¬ÁÕ¸ú¤·¤¿1Îã ¤ò¿½¹þ¤à 
 
¡ùCPT-11/S-1½ÑÁ°²½³ØÎÅË¡¤¬ÁÕ¸ú¤·º¬¼£ÀÚ½ü¤·ÆÀ¤¿¿Ê¹Ô°ß´â¤Î1Îã

  ¢£Âç·¿3·¿¿Ê¹Ô°ß´â¡¡CPT-11/S-1.Ê»ÍÑ...½ÑÁ°²½³ØÎÅË¡.»Ü¹Ô¡¡¥ê¥ó¥ÑÀáž°ÜÁã.Ãø¸ú¡¡º¬¼£ÀÚ½ü²Äǽ....1Îã¡¡69ºÐ,½÷À­...

  ¢£*1Ê¡Å縩Ω°å²ÊÂç³Ø¡¦Âè°ì³°²Ê, *2Ê¡Å縩Ω°å²ÊÂç³Ø¡¦ÉÂÍý...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ù

º£¤¹¤° CPT-11/S-1½ÑÁ°²½³ØÎÅË¡¤¬ÁÕ¸ú¤·º¬¼£ÀÚ½ü¤·ÆÀ¤¿¿Ê¹Ô°ß´â¤Î1Îã ¤ò¿½¹þ¤à 
 
¡ùËýÀ­¿ÕÉÔÁ´¤òÍ­¤¹¤ëÂçIJ´â¾ÉÎã¤ËÂФ¹¤ë·ì±ÕÆ©ÀÏÊ»ÍÑ FOLFOX 4ÎÅË¡¤Î1Îã

  ¢£ËýÀ­¿ÕÉÔÁ´..¿Í¹©Æ©ÀÏ.ƳÆþ.....68ºÐ.½÷À­¡¡S ¾õ·ëIJ´â½Ñ¸å´Îž°Ü.ÂÐ..CPT-11+UFT+LeucovorinÎÅË¡.¼¡¼£ÎÅ...FOLFOX 4ÎÅË¡.¼Â»Ü¡¡ËýÀ­¿ÕÉÔÁ´...

  ¢£*1NTTÀ¾ÆüËÜÂçºåɱ¡¡¦³°²Ê, *2NTTÀ¾ÆüËÜÂçºåɱ¡¡¦...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ù

º£¤¹¤° ËýÀ­¿ÕÉÔÁ´¤òÍ­¤¹¤ëÂçIJ´â¾ÉÎã¤ËÂФ¹¤ë·ì±ÕÆ©ÀÏÊ»ÍÑ FOLFOX 4ÎÅË¡¤Î1Îã ¤ò¿½¹þ¤à 
 
¡ùCisplatin¤ÈIrinotecan¤¬Ãø¸ú¤·¤¿Á°Î©Á£¿À·ÐÆâʬÈç´â¤Î1Îã

  ¢£´µ¼Ô.79ºÐ,ÃËÀ­¡¡prostatic adenocarcinoma.ÉÂÍý¿ÇÃÇ¡¡¿À·ÐÆâʬÈçʬ²½.¼¨..Á°Î©Á£´â.ž°Ü¡¡CDDP .CPT-11.ÍÑ..²½³ØÎÅË¡.»Ü¹Ô¡¡CT ..´ÎÉÂ...

  ¢£*1¾¾»³ÀÖ½½»úɱ¡¡¦ÈçÇ¢´ï²Ê, *2¾¾»³ÀÖ½½»úɱ¡¡¦ÌôºÞÉô,...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ù

º£¤¹¤° Cisplatin¤ÈIrinotecan¤¬Ãø¸ú¤·¤¿Á°Î©Á£¿À·ÐÆâʬÈç´â¤Î1Îã ¤ò¿½¹þ¤à 
 
¡ùCetuximab¡¡Ê¬»ÒɸŪÌô¤ÎºÇ¶á¤ÎÏÃÂê

  ¢£Cetuximab.ËÜË®....Î×¾²»î¸³.¸½¾õ¡¡BOND-1...BOND-2 ¥È¥é¥¤¥¢¥ë È鿾.½Å¾ÉÅÙ.¹³¼ðáç¸ú²Ì.´Ø·¸¡¡First-line....»î¸³À®ÀÓ¡¡2007ǯAAC...

  ¢£*Âçºå°å²ÊÂç³ØÉí°É±¡¡¦²½³ØÎÅË¡¥»¥ó¥¿¡¼...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ù

º£¤¹¤° Cetuximab¡¡Ê¬»ÒɸŪÌô¤ÎºÇ¶á¤ÎÏÃÂê ¤ò¿½¹þ¤à 
 
¡ùCPT-11+CDDPÊ»ÍÑÎÅË¡¤ÈÊü¼ÍÀþÊ»ÍÑÎÅË¡¤¬Í­¸ú¤Ç¤¢¤Ã¤¿°ß´âǾž°Ü¤Î2Îã

  ¢£63ºÐ,ÃËÀ­¡¡Â¿È¯Ç¾Å¾°Ü.¿ÇÃÇ¡¡Á´Ç¾¾È¼Í(·×30Gy).CPT-11+CDDP .¼Â»Ü¡¡Å¾°Ü.ÂÐ..¼£ÎŸú²Ì.PR¡¡78ºÐ,ÃËÀ­¡¡CT ..¿ȯǾž°Ü.ǧ..¡¡CPT-11+CDD...

  ¢£*1²£ÉÍ»ÔΩÂç³Ø¡¦³°²Ê¼£ÎųØ, *2²£ÉÍ»ÔΩÂç³Ø¡¦Ç¾¿À·Ð³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ù

º£¤¹¤° CPT-11+CDDPÊ»ÍÑÎÅË¡¤ÈÊü¼ÍÀþÊ»ÍÑÎÅË¡¤¬Í­¸ú¤Ç¤¢¤Ã¤¿°ß´âǾž°Ü¤Î2Îã ¤ò¿½¹þ¤à 
 
¡ùCPT-11¤Ë¤Æ¼ðá礬¾Ã¼º¤·¤¿°ß´â´Îž°Ü¤Î1Îã

  ¢£¾ÉÎã.71ºÐ,ÃËÀ­¡¡´û±ýÎò.¶¹¿´¾É¡¡Í©Ì禰ßÀÚ½ü½Ñ¡¡»Ä°ß´â.´Îž°Ü.¿ÇÃÇ¡¡´Îž°ÜÁã.¾Ã¼º¡¡2ǯ·Ð²á..¸½ºß.ºÆÈ¯..·òºß¡¡...

  ¢£*̾¸Å²°ÙպѲñɱ¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ù

º£¤¹¤° CPT-11¤Ë¤Æ¼ðá礬¾Ã¼º¤·¤¿°ß´â´Îž°Ü¤Î1Îã ¤ò¿½¹þ¤à 
 
¡ùOxaliplatin Plus 5-Fluorouracil/Leucovorin (FOLFOX-4) as Salvage Chemotherapy in Patients with Pretreated Colorectal Cancer

  ¢£¼£ÎÅÂçIJ´â¾ÉÎã.ÂÐ..FOLFOX-4ÎÅË¡.Í­¸úÀ­.°ÂÁ´À­.¸¡Æ¤¡¡FOLFOX-4ÎÅË¡.³«»Ï...´û¼£ÎÅÎã20Îã¡¡FOLFOX-4ÎÅË¡.À¸Â¸´ü´Ö±äĹ.´óÍ¿¡¡Ê¬»ÒɸŪºÞ..Ê»ÍÑ......

  ¢£*Department of Medical Oncolog...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ù

º£¤¹¤° Oxaliplatin Plus 5-Fluorouracil/Leucovorin (FOLFOX-4) as Salvage Chemotherapy in Patients with Pretreated Colorectal Cancer ¤ò¿½¹þ¤à 
 
¡ùTaxane(TX)ÂÑÀ­¤ÎºÆÈ¯¡¦Å¾°ÜÆý´â¤ËÂФ¹¤ë¼£Îť쥸¥á¥ó¤Î¸¡Æ¤

  ¢£2001ǯ1·î..2006ǯ5·î¡¡292ÎãÃæ246Îã.taxane(TX:docetaxel ... paclitaxel).ÅêÍ¿¡¡TX ÁÕ¸úÎã.̵¸úÎã.Èæ...±äÌ¿·¹¸þ...

  ¢£1Èæ±Ãɱ¡¡¦³°²Ê, *2ÆýÁ£¥¯¥ê¥Ë¥Ã¥¯»ù¶Ì³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ù

º£¤¹¤° Taxane(TX)ÂÑÀ­¤ÎºÆÈ¯¡¦Å¾°ÜÆý´â¤ËÂФ¹¤ë¼£Îť쥸¥á¥ó¤Î¸¡Æ¤ ¤ò¿½¹þ¤à 
 
¡ù4·¿°ß´â¤ËÂФ¹¤ë¼£ÎÅÀïά-Æâ²Ê¤ÎΩ¾ì¤«¤é-

  ¢£¿Ê¹Ô°ß´â.Èæ³Ó..ÉÔÎÉ¡¡ ¹âΨ.Ê¢Ëìž°Ü.¹çÊ» ͽ¸å±äĹ..Á´¿È²½³ØÎÅË¡.½ÅÍ× ¡¡S-1¥ì¥¸¥á¥ó...½ÑÁ°²½³ØÎÅË¡.½Ñ¸å²½³ØÎÅË¡.....¹â.Í­¸úÀ­¡¡ Í­¸ú.ÌôºÞ.»È.ÀÚ....ͽ...

  ¢£*1ËÌΤÂç³ØÅìɱ¡¡¦¾Ã²½´ïÆâ²Ê, *2ËÌΤÂç³ØÉ±¡¡¦¾Ã²½´ïÆâ...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ù

º£¤¹¤° 4·¿°ß´â¤ËÂФ¹¤ë¼£ÎÅÀïά-Æâ²Ê¤ÎΩ¾ì¤«¤é- ¤ò¿½¹þ¤à 
 
¡ùÊ¢ËìÇżï¤òȼ¤¦¿Ê¹Ô°ß´â¤ÎFourth-Line¤ÇS-1ñºÞ¤¬Ãø¸ú¤·¤¿1Îã

  ¢£¾ÉÎã.42ºÐ,½÷À­¡¡Ê¢ËìÇżï.ȼ.ÀÚ½üÉÔǽ.¹âÅٿʹ԰ߴâ.¿ÇÃÇ¡¡fourth-line...S-1ñºÞÎÅË¡.»Ü¹Ô¡¡³«»Ï..8.·î´ÖSD .¾õÂÖ.Îɹ¥.PS .ÊÝ.Ʊ¼£ÎÅ.·Ñ³...

  ¢£*1Éðͺ»ÔΩÉðͺ»Ô̱ɱ¡¡¦³°²Ê, *2¶å½£¸üÀ¸Ç¯¶âɱ¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ù

º£¤¹¤° Ê¢ËìÇżï¤òȼ¤¦¿Ê¹Ô°ß´â¤ÎFourth-Line¤ÇS-1ñºÞ¤¬Ãø¸ú¤·¤¿1Îã ¤ò¿½¹þ¤à 
 
¡ùS-1Ê»ÍѲ½³ØÊü¼ÍÀþÎÅË¡¤Ë¤è¤êQOL¤Î²þÁ±¤¬ÆÀ¤é¤ì¤¿ç¹Æ¬Éô´â¤Î1Îã

  ¢£S-1Ê»ÍÑ...²½³ØÊü¼ÍÀþÎÅË¡.Âè­µÁê»î¸³.¹Ô..¹â.¹³¼ðáç¸ú²Ì.Êó¹ð¡¡¾ÉÎã.70ºÐ,ÃËÀ­¡¡ç¹Æ¬Éô´â.¿ÇÃÇ¡¡S-1Ê»ÍѲ½³ØÊü¼ÍÀþÎÅË¡¡¡S-1...³°Íè¼£ÎÅ..°Ü¹Ô¡¡ºß.qualit...

  ¢£*1¹°Á°Âç³Ø°å³ØÉô¡¦Æâ²Ê³ØÂè°ì¹ÖºÂ, *2»°Âô»ÔΩ»°Âôɱ¡¡¦...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° S-1Ê»ÍѲ½³ØÊü¼ÍÀþÎÅË¡¤Ë¤è¤êQOL¤Î²þÁ±¤¬ÆÀ¤é¤ì¤¿ç¹Æ¬Éô´â¤Î1Îã ¤ò¿½¹þ¤à 
 
¡ù¥Ì¡¼¥É¥Þ¥¦¥¹²Ä°Ü¿¢À­¥Ò¥È°ß´â³ô¤Ë¤ª¤±¤ëÀ©´âºÞÊ»ÍÑÎÅË¡¤Î¸¡Æ¤

  ¢£ºàÎÁ.ÊýË¡¡¡·ë²Ì¡¡¹Í»¡¡¡¥Ì¡¼¥É¥Þ¥¦¥¹²Ä°Ü¿¢À­¥Ò¥È°ß´â³ô.ÍÑ..CPT-11Ê»ÍÑÎÅË¡.¸ú²ÌÁý¶¯ºîÍÑ.³Îǧ¡¡Î¾¹³´âºÞ´¶¼õÀ­»î¸³.Áê´Ø.Èæ³Ó¸¡Æ¤¡¡CPT-11.CDDP ..Ê»ÍÑÎÅË¡.....

  ¢£*ÆüËÜÂç³Ø°å³ØÉô¡¦³°²Ê³Ø¹ÖºÂ¡¦¾Ã²½´ï³°²ÊÉôÌç...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° ¥Ì¡¼¥É¥Þ¥¦¥¹²Ä°Ü¿¢À­¥Ò¥È°ß´â³ô¤Ë¤ª¤±¤ëÀ©´âºÞÊ»ÍÑÎÅË¡¤Î¸¡Æ¤ ¤ò¿½¹þ¤à 
 
¡ùÀÚ½üÉÔǽÂçIJ´â´Îž°Ü¤ËÂФ·½¸³ØÅª¼£ÎŤˤÆÄ¹´üÀ¸Â¸¤¬ÆÀ¤é¤ì¤Æ¤¤¤ë1Îã

  ¢£¾ÉÎã.79ºÐ,ÃËÀ­¡¡S¾õ·ëIJ´â.ÂÐ.S ¾õ·ëIJÀÚ½ü½Ñ»Ü¹Ô¡¡Â¿È¯À­´Îž°Ü.ÂÐ.½¸³ØÅª¼£ÎÅ.¹Ô.,´Îž°Üȯ¸½..6ǯ11.·îÀ¸Â¸.Ĺ´ü±äÌ¿.ÆÀ.....¾ÉÎã...

  ¢£*µÜºê¸©Î©±ä²¬É±¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° ÀÚ½üÉÔǽÂçIJ´â´Îž°Ü¤ËÂФ·½¸³ØÅª¼£ÎŤˤÆÄ¹´üÀ¸Â¸¤¬ÆÀ¤é¤ì¤Æ¤¤¤ë1Îã ¤ò¿½¹þ¤à 
 
¡ù°ß´â¤ËÂФ¹¤ëS-1+CPT-11ÎÅË¡Î×¾²»î¸³¸å¤ÎSecond-Line²½³ØÎÅË¡

  ¢£progressive disease(PD)....44Îã...32Îã.second-line²½³ØÎÅË¡.»Ü¹Ô¡¡¼£Îų«»Ï...À¸Â¸´ü´Ö.Í­°Õ.±äĹ¡¡¥ì¥¸¥á¥ó.S-1Ê»ÍÑ·².ÈóÊ»ÍÑ·²...

  ¢£*1Åìµþ°å²Ê»õ²ÊÂç³Ø¡¦¿©Æ»°ß³°²Ê, *2Ï»¥ÄÌÚ¿ÇÎŽê, *3...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° °ß´â¤ËÂФ¹¤ëS-1+CPT-11ÎÅË¡Î×¾²»î¸³¸å¤ÎSecond-Line²½³ØÎÅË¡ ¤ò¿½¹þ¤à 
 
¡ù¾å¹Ô·ëIJ´âÀÚ½ü¸å¤Îž°Ü¥ê¥ó¥ÑÀá°ä»Ä¤ËÂФ·S-1/CPT-11Ê»ÍÑÎÅË¡¤ò¹Ô¤¤CR¤¬ÆÀ¤é¤ì¤¿1Îã

  ¢£¾ÉÎã¡¡¹Í»¡¡¡50ºÐ,ÃËÀ­¡¡²¼Éô¾Ã²½´ÉÆâ»ë¶À¸¡ºº¡¡CEA .ÃøÌÀ.¾å¾º¡¡Å¾°ÜºÆÈ¯¡¡ÀÚ½üÉÔǽÂçIJ´â¡¡Í­¸ú.¼£ÎÅË¡.°ì....´üÂÔ¡¡...

  ¢£*1Ê¡²¬Âç³ØÃÞ»çɱ¡¡¦³°²Ê, *2´ÅÌÚÃæ±ûɱ¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° ¾å¹Ô·ëIJ´âÀÚ½ü¸å¤Îž°Ü¥ê¥ó¥ÑÀá°ä»Ä¤ËÂФ·S-1/CPT-11Ê»ÍÑÎÅË¡¤ò¹Ô¤¤CR¤¬ÆÀ¤é¤ì¤¿1Îã ¤ò¿½¹þ¤à 
 
¡ùPaclitaxel/TS-1Ê»ÍÑÎÅË¡¤ÈCPT-11/CisplatinÊ»ÍÑÎÅË¡¤¬Ãø¸ú¤ò¼¨¤·¤¿ÊĺÉÀ­²«áÕ,¿ȯ´Îž°Ü¤òȼ¤¦¿Ê¹Ô°ß´â¤Î1Îã

  ¢£¾ÉÎã.60ºÐ,ÃËÀ­¡¡Èæ³ÓŪĹ´ü.À¸Â¸.ÆÀ.ÊĺÉÀ­²«áÕ,¿ȯ´Îž°Ü.ȼ.¿Ê¹Ô°ß´â.1Îã¡¡paclitaxel/TS-1Ê»ÍÑÎÅË¡.»Ü¹Ô¡¡irinotecan/cisplatinÊ»ÍÑÎÅË¡...

  ¢£*1ÆüËÜ»õ²ÊÂç³Ø¿·³ãÀ¸Ì¿»õ³ØÉô¡¦Æâ²Ê³Ø¹ÖºÂ, *2ϫƯ¼Ô·ò¹¯...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° Paclitaxel/TS-1Ê»ÍÑÎÅË¡¤ÈCPT-11/CisplatinÊ»ÍÑÎÅË¡¤¬Ãø¸ú¤ò¼¨¤·¤¿ÊĺÉÀ­²«áÕ,¿ȯ´Îž°Ü¤òȼ¤¦¿Ê¹Ô°ß´â¤Î1Îã ¤ò¿½¹þ¤à 
 
¡ù¿Ê¹Ô¡¦ºÆÈ¯ÂçIJ´â¤ËÂФ¹¤ëSecond-Line¤â¤·¤¯¤ÏThird-Line¤È¤·¤ÆCPT-11¡ÜTS-1ÎÅË¡¤ò»Ü¹Ô¤·¤¿5Îã

  ¢£second-line....third-line...CPT-11+TS-1.ÁÈ.¹ç..¡¡³°Íè¼£ÎÅ...5Îã.´µ¼Ô¡¡5-FU.Ãæ¿´...¼£ÎŸå..¸ú²Ì.´üÂÔ¡¡³°ÍèÄ̱¡..°ÂÁ´.»Ü...

  ¢£µÜºê¸©Î©±ä²¬É±¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° ¿Ê¹Ô¡¦ºÆÈ¯ÂçIJ´â¤ËÂФ¹¤ëSecond-Line¤â¤·¤¯¤ÏThird-Line¤È¤·¤ÆCPT-11¡ÜTS-1ÎÅË¡¤ò»Ü¹Ô¤·¤¿5Îã ¤ò¿½¹þ¤à 
 
¡ù½Ñ¸å¤Ë²½³ØÎÅË¡¤ò»Ü¹Ô¤·Ä¹´üÀ¸Â¸¤¬ÆÀ¤é¤ì¤Æ¤¤¤ë°ß¾®ºÙ˦´â¤Î1Îã-¾®ºÙ˦´â¤ËÂФ¹¤ë²½³ØÎÅË¡»Ü¹ÔÎã¤Î¸¡Æ¤-

  ¢£°ß.¾®ºÙ˦´â¡¡²½³ØÎÅË¡.»Ü¹Ô.,Ĺ´üÀ¸Â¸.ÆÀ.1Îã¡¡¾ÉÎã.75ºÐ,ÃËÀ­¡¡Â¿È¯À­´Îž°Ü.½Ð¸½¡¡TS-1+CDDP.»Ü¹Ô¡¡CPT-11+CDDP.»Ü¹Ô...

  ¢£»ÔΩÃÓÅÄɱ¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° ½Ñ¸å¤Ë²½³ØÎÅË¡¤ò»Ü¹Ô¤·Ä¹´üÀ¸Â¸¤¬ÆÀ¤é¤ì¤Æ¤¤¤ë°ß¾®ºÙ˦´â¤Î1Îã-¾®ºÙ˦´â¤ËÂФ¹¤ë²½³ØÎÅË¡»Ü¹ÔÎã¤Î¸¡Æ¤- ¤ò¿½¹þ¤à 
 
¡ù·Ð¸ýUFT/LV+CPT-11ÎÅË¡¤¬ÁÕ¸ú¤·º¬¼£ÀÚ½ü¤¬²Äǽ¤È¤Ê¤Ã¤¿¹âÅÙ¿»½áľIJ´â¤Î1Îã

  ¢£¾ÉÎã.72ºÐ,ÃËÀ­¡¡ÀÚ½üÉÔǽľIJ´â..¿ÇÃÇ¡¡½Ñ¸å.·Ð¸ýUFT/LV+low-dose CPT-11...³°Íè²½³ØÎÅË¡.¹Ô..¡¡º¬¼£¼ê½Ñ.»Ü¹Ô¡¡½Ñ¸å1ǯ7.·î.·Ð²á..¸½ºß.̵ºÆÈ¯À¸...

  ¢£*¹âº½¶¨Î©É±¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° ·Ð¸ýUFT/LV+CPT-11ÎÅË¡¤¬ÁÕ¸ú¤·º¬¼£ÀÚ½ü¤¬²Äǽ¤È¤Ê¤Ã¤¿¹âÅÙ¿»½áľIJ´â¤Î1Îã ¤ò¿½¹þ¤à 
 1 - 20 ÈÖÌܤòɽ¼¨ (233 ¤¢¤ëÏÀʸ¤Î¤¦¤Á)   ¥Ú¡¼¥¸:  1  2  3  4  5 ...  [¼¡¥Ú¡¼¥¸ >>]  
Á°¤ËÌá¤ë
°ÊÁ°¤´ÍøÍѤµ¤ì¤¿Êý
E-Mail ¥¢¥É¥ì¥¹:
¥Ñ¥¹¥ï¡¼¥É:
¥Ñ¥¹¥ï¡¼¥Éʶ¼º
Åê¹Æ¥µ¡¼¥Á
 
¤Á¤ç¤Ã¤È½Å¤¤¤Ç¤¹
´ØÏ¢¤Î¤¢¤ë½ñÀÒ
¥ì¥Ó¥å¡¼

»ä¤Î¤è¤¦¤ÊÁǿͤǤ⡢¤ï¤«¤ê¤ä¤¹¤¯½ñ¤«¤ì¤¤¤Æ¤¤¤¿°Ù¤ËÂçÊÑ»²¹Í¤Ë ..
5ÅÀÃæ¤Î 5ÅÀ!
       TOP ¥¢¥«¥¦¥ó¥È¾ðÊó  |  ¥«¡¼¥È¤ò¸«¤ë  |  ¥ì¥¸¤Ë¿Ê¤à